Immunological and biochemical characterization of streptococcal pyrogenic exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes

被引:40
作者
Proft, T
Arcus, VL
Handley, V
Baker, EN
Fraser, JD
机构
[1] Univ Auckland, Sch Med, Div Mol Med, Auckland, New Zealand
[2] Univ Auckland, Sch Biol Sci, Auckland, New Zealand
关键词
D O I
10.4049/jimmunol.166.11.6711
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recently, we described the identification of novel streptococcal superantigens (SAgs) by mining the Streptococcus pyogenes M1 genome database at Oklahoma University. Here, we report the cloning, expression, and functional analysis of streptococcal pyrogenic exotoxin (SPE)-J and another novel SAg (SPE-I). SPE-1 is most closely related to SPE-H and staphylococcal enterotoxin I, whereas SPE-J is most closely related to SPE-C. Recombinant forms of SPE-I and SPE-J were mitogenic for PBL, both reaching half maximum responses at 0.1 pg/ml. Evidence from binding studies and cell aggregation assays using a human B -lymphoblastoid cell line (LG-2) suggests that both toxins exclusively bind to the polymorphic MHC class Alpha-chain in a zinc-dependent mode but not to the generic MHC class II a-chain. The results from analysis by light scattering indicate that SPE-J exists as a dimer in solution above concentrations of 4.0 mg/ml. Moreover, SPE-J induced a rapid homotypic aggregation of LG-2 cells, suggesting that this toxin might cross-link MHC class II molecules on the cell surface by building tetramers of the type HLA-DRG-SPE-J-SPE J-HLA-DR beta. SPE-I preferably stimulates T cells bearing the V beta 18.1 TCR, which is not targeted by any other known SAg. SPE-J almost exclusively stimulates V beta2.1 T cells, a V beta that is targeted by several other streptococcal SAgs, suggesting a specific role for this T cell subpopulation in immune defense. Despite a primary sequence diversity of 51%, SPE-J is functionally indistinguisabable from SPE-C and might play a role in streptococcal disease, which has previously been addressed to SPE-C. The Journal of immunology, 2001,
引用
收藏
页码:6711 / 6719
页数:9
相关论文
共 50 条
[1]   SELECTIVE EXPANSION OF T-CELLS EXPRESSING T-CELL RECEPTOR VARIABLE REGIONS V-BETA-2 AND V-BETA-8 IN KAWASAKI-DISEASE [J].
ABE, J ;
KOTZIN, BL ;
JUJO, K ;
MELISH, ME ;
GLODE, MP ;
KOHSAKA, T ;
LEUNG, DYM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :4066-4070
[2]   STRUCTURAL BASIS OF SUPERANTIGEN ACTION INFERRED FROM CRYSTAL-STRUCTURE OF TOXIC-SHOCK SYNDROME TOXIN-1 [J].
ACHARYA, KR ;
PASSALACQUA, EF ;
JONES, EY ;
HARLOS, K ;
STUART, DI ;
BREHM, RD ;
TRANTER, HS .
NATURE, 1994, 367 (6458) :94-97
[3]  
ALOUF JE, 1999, SOURCEBOOK BACTERIAL, P567
[4]   Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes [J].
Arcus, VL ;
Proft, T ;
Sigrell, JA ;
Baker, HM ;
Fraser, JD ;
Baker, EN .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 299 (01) :157-168
[5]   Superantigens in human disease [J].
Bernal, A ;
Proft, T ;
Fraser, JD ;
Posnett, DN .
JOURNAL OF CLINICAL IMMUNOLOGY, 1999, 19 (03) :149-157
[6]  
BETLEY MJ, 1992, CHEM IMMUNOL, V55, P1
[7]   STAPHYLOCOCCAL AND STREPTOCOCCAL PYROGENIC TOXINS INVOLVED IN TOXIC SHOCK SYNDROME AND RELATED ILLNESSES [J].
BOHACH, GA ;
FAST, DJ ;
NELSON, RD ;
SCHLIEVERT, PM .
CRITICAL REVIEWS IN MICROBIOLOGY, 1990, 17 (04) :251-272
[8]   CLINICAL AND BACTERIOLOGICAL OBSERVATIONS OF A TOXIC SHOCK-LIKE SYNDROME DUE TO STREPTOCOCCUS-PYOGENES [J].
CONE, LA ;
WOODARD, DR ;
SCHLIEVERT, PM ;
TOMORY, GS .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (03) :146-149
[9]   SUPERANTIGENS INTERACT WITH MHC CLASS-II MOLECULES OUTSIDE OF THE ANTIGEN GROOVE [J].
DELLABONA, P ;
PECCOUD, J ;
KAPPLER, J ;
MARRACK, P ;
BENOIST, C ;
MATHIS, D .
CELL, 1990, 62 (06) :1115-1121
[10]   TOXIC SHOCK SYNDROME-ASSOCIATED STAPHYLOCOCCAL AND STREPTOCOCCAL PYROGENIC TOXINS ARE POTENT INDUCERS OF TUMOR NECROSIS FACTOR PRODUCTION [J].
FAST, DJ ;
SCHLIEVERT, PM ;
NELSON, RD .
INFECTION AND IMMUNITY, 1989, 57 (01) :291-294